Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 336

1.

Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies.

Ohnuma K, Isoyama K, Ikuta K, Toyoda Y, Nakamura J, Nakajima F, Tsuchida M, Ohira M, Suminoe A, Hara T, Nishihira H.

Br J Haematol. 2001 Mar;112(4):981-7.

PMID:
11298596
2.

Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group.

Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, Messina C, Ortega J, Badell-Serra I, Plouvier E, Souillet G, Jouet JP, Pasquini R, Ferreira E, Garnier F, Gluckman E.

Blood. 1999 Jun 1;93(11):3662-71.

3.

Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT).

Schmitz N, Bacigalupo A, Labopin M, Majolino I, Laporte JP, Brinch L, Cook G, Deliliers GL, Lange A, Rozman C, Garcia-Conde J, Finke J, Domingo-Albos A, Gratwohl A.

Br J Haematol. 1996 Dec;95(4):715-23.

PMID:
8982051
4.

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, Oakill A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Wernet P, Sirchia G, Rubinstein P, Chevret S, Gluckman E.

Blood. 2001 May 15;97(10):2962-71.

5.

The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis.

Nishihira H, Kato K, Isoyama K, Takahashi TA, Kai S, Kato S, Takanashi M, Sato N, Sato H, Kitajima K, Naoe T, Saito H.

Br J Haematol. 2003 Feb;120(3):516-22.

PMID:
12580971
6.

[Allogeneic hematopoietic stem cell transplantation for treatment of Philadelphia chromosome positive acute lymphoblastic leukemia].

Xu LP, Huang XJ, Liu KY, Chen H, Liu DH, Zhang YC, Chen YH, Han W, Gao ZY, Lu DP.

Beijing Da Xue Xue Bao. 2005 Jun 18;37(3):231-5. Chinese.

7.

Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.

Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D.

Klin Padiatr. 2004 Nov-Dec;216(6):356-63.

PMID:
15565551
8.

Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome.

Green A, Clarke E, Hunt L, Canterbury A, Lankester A, Hale G, Waldmann H, Goodman S, Cornish JM, Marks DI, Steward CG, Oakhill A, Pamphilon DH.

Blood. 1999 Oct 1;94(7):2236-46.

9.

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.

Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.

Biol Blood Marrow Transplant. 2009 Feb;15(2):257-65. doi: 10.1016/j.bbmt.2008.11.025.

10.

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.

Gürman G, Arat M, Ilhan O, Konuk N, Beksaç M, Celebi H, Ozcan M, Arslan O, Ustün C, Akan H, Uysal A, Koç H.

Cytotherapy. 2001;3(4):253-60.

PMID:
12171713
11.

Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation.

Guardiola P, Kuentz M, Garban F, Blaise D, Reiffers J, Attal M, Buzyn A, Lioure B, Bordigoni P, Fegueux N, Tanguy ML, Vernant JP, Gluckman E, Socié G.

Br J Haematol. 2000 Oct;111(1):292-302.

PMID:
11091216
12.

Cord blood transplantation from HLA-mismatched unrelated donors.

Ohnuma K, Isoyama K, Nishihira H.

Leuk Lymphoma. 2002 May;43(5):1029-34.

PMID:
12148882
13.

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.

Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.

14.

Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?

Ringdén O, Labopin M, Gorin NC, Schmitz N, Schaefer UW, Prentice HG, Bergmann L, Jouet JP, Mandelli F, Blaise D, Fouillard L, Frassoni F; Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation.

Br J Haematol. 2000 Dec;111(4):1130-7.

PMID:
11167752
15.

[Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].

Starý J, Kobylka P, Sedlácek P, Komrska V, Vávra V, Syrůcková Z, Smísek P, Hrubá A, Korínková P, Matĕjková E, Cukrová V, Dolezalová L, Loudová M, Sejkorová J, Kvĕch J.

Cas Lek Cesk. 1998 Jun 15;137(12):363-7. Czech.

PMID:
9721472
16.

Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome.

Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C, Fagioli F, Porta F, Favre C, Pession A, Locatelli F; AIEOP-BMT Group. Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplant.

Blood. 2002 Aug 15;100(4):1192-200.

17.

Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors.

Kröger N, Zabelina T, Krüger W, Renges H, Stute N, Dürken M, Graf von Finkenstein F, Erttmann R, Kabisch H, Schafhausen P, Jaburg N, Löliger C, Zander AR.

Ann Hematol. 2001 Apr;80(4):209-15.

PMID:
11401086
18.

Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.

Haematologica. 2002 Jan;87(1):52-8.

19.

Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes.

Kato K, Yoshimi A, Ito E, Oki K, Hara J, Nagatoshi Y, Kikuchi A, Kobayashi R, Nagamura-Inoue T, Kai S, Azuma H, Takanashi M, Isoyama K, Kato S; Japan Cord Blood Bank Network.

Biol Blood Marrow Transplant. 2011 Dec;17(12):1814-21. doi: 10.1016/j.bbmt.2011.05.013. Epub 2011 May 25.

20.

Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia.

Elmaagacli AH, Basoglu S, Peceny R, Trenschel R, Ottinger H, Lollert A, Runde V, Grosse-Wilde H, Beelen DW, Schaefer UW.

Blood. 2002 Feb 15;99(4):1130-5.

Supplemental Content

Support Center